Free Trial
NASDAQ:AZTA

Azenta (AZTA) Stock Price, News & Analysis

Azenta logo
$51.97 -0.12 (-0.23%)
Closing price 02/4/2025 04:00 PM Eastern
Extended Trading
$51.98 +0.01 (+0.01%)
As of 02/4/2025 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Azenta Stock (NASDAQ:AZTA)

Key Stats

Today's Range
$50.13
$52.43
50-Day Range
$44.49
$54.75
52-Week Range
$38.82
$67.77
Volume
822,324 shs
Average Volume
425,903 shs
Market Capitalization
$2.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$57.25
Consensus Rating
Moderate Buy

Company Overview

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Azenta Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
55th Percentile Overall Score

AZTA MarketRank™: 

Azenta scored higher than 55% of companies evaluated by MarketBeat, and ranked 529th out of 955 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Azenta has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Azenta has only been the subject of 2 research reports in the past 90 days.

  • Read more about Azenta's stock forecast and price target.
  • Earnings Growth

    Earnings for Azenta are expected to grow by 92.68% in the coming year, from $0.41 to $0.79 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Azenta is -17.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Azenta is -17.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Azenta has a P/B Ratio of 1.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Azenta's valuation and earnings.
  • Percentage of Shares Shorted

    9.41% of the float of Azenta has been sold short.
  • Short Interest Ratio / Days to Cover

    Azenta has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

    Short interest in Azenta has recently increased by 1.93%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Azenta does not currently pay a dividend.

  • Dividend Growth

    Azenta does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.41% of the float of Azenta has been sold short.
  • Short Interest Ratio / Days to Cover

    Azenta has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

    Short interest in Azenta has recently increased by 1.93%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Azenta has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Azenta this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for AZTA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Azenta to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Azenta insiders have bought 1,648.63% more of their company's stock than they have sold. Specifically, they have bought $997,067.00 in company stock and sold $57,020.00 in company stock.

  • Percentage Held by Insiders

    10.62% of the stock of Azenta is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    99.08% of the stock of Azenta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Azenta's insider trading history.
Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

AZTA Stock News Headlines

Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently?
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?
Azenta: Taking A Pass
Azenta selected as technology provider by UK Biocentre
See More Headlines

AZTA Stock Analysis - Frequently Asked Questions

Azenta's stock was trading at $50.00 at the start of the year. Since then, AZTA shares have increased by 3.9% and is now trading at $51.97.
View the best growth stocks for 2025 here
.

Azenta, Inc. (NASDAQ:AZTA) announced its quarterly earnings results on Tuesday, November, 12th. The company reported $0.18 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.08. The firm's revenue for the quarter was down 1.2% compared to the same quarter last year.

Top institutional shareholders of Azenta include Conestoga Capital Advisors LLC (3.45%), Allspring Global Investments Holdings LLC (2.88%), Stephens Investment Management Group LLC (1.52%) and Bank of New York Mellon Corp (0.87%). Insiders that own company stock include John Marotta, David C Gray, Matthew Mcmanus, Herman Cueto, Olga Pirogova, William L Cornog, Violetta Hughes and Kimberly Crowley.
View institutional ownership trends
.

Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Azenta investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
11/12/2024
Today
2/04/2025
Next Earnings (Estimated)
2/05/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Special industry machinery, not elsewhere classified
Sub-Industry
Machinery
Current Symbol
NASDAQ:AZTA
Employees
3,300
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$57.25
High Stock Price Target
$64.00
Low Stock Price Target
$50.00
Potential Upside/Downside
+10.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-164,170,000.00
Pretax Margin
-25.49%

Debt

Sales & Book Value

Annual Sales
$656.32 million
Cash Flow
$4.37 per share
Book Value
$36.16 per share

Miscellaneous

Free Float
40,840,000
Market Cap
$2.37 billion
Optionable
Optionable
Beta
1.47
10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:AZTA) was last updated on 2/5/2025 by MarketBeat.com Staff
From Our Partners